CLINDAMYCIN PHOSPHATE | A065049 | PADAGIS US LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Husch Blackwell, LLP FDA-2019-P-5403 · 8 docket documents Husch Blackwell LLP, on behalf of an unnamed client, filed a citizen petition under Section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate ANDA No. 065049 (Clindamycin Phosphate Topical Solution USP, 1% (Pledgets)) by Perrigo New York, Inc. as a Reference Standa | 505(q) | 2019-11-15 | Withdrawn | Husch Blackwell, LLP |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.2881
per ea
Lowest NADAC/Unit
$0.2881
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 45802026337CLINDAMYCIN PHOS 1% PLEDGET | $0.2881 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.